Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Location: Chevy Chase MD, Warner Robins GA, Naperville IL,
Sponsor: Align Technology, Inc.
Sex: All
Age: 6 - 11
Code: NCT06662279
Recruiting
A Pilot Study of a Commercially-available Oil Rinse Product (PerioPullâ„¢) on Markers of Dental Health
for
Oral Health
Location: Ellicott City MD
Sponsor: Designs for Health
Sex: All
Age: 18+
Code: NCT06363721
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase1, Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: New York NY, Lancaster PA, Baltimore MD,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05413421
Phase1, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
for
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis,
Location: Bethesda MD, Frederick MD, Durham NC, Chapel Hill NC,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07332091
Phase2, Recruiting
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease